Opioid Overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Within 10 months of a nonfatal opioid overdose, 91% of patients again received opioid prescriptions, one-third received high-dose opioids, 58% received a benzodiazepine, and 7% had a repeat overdose,

Effect: adverse; 91% received opioid prescriptions again within 10 months; 7% had repeat overdose

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste

Opioid overdose rates were lowest in the third trimester (3.3 per 100,000 person-days) then increased sharply in the postpartum period, with the highest rate at 7-12 months after delivery (12.3 per 10

Effect: decline; 3.3 per 100,000 person-days (3rd trimester) rising to 12.3 per 100,000 person-days (7-12 months postpartum); CI: 95% CI 1.6-6.1 (3rd trimeste